Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

End-of-day quote. End-of-day quote  - 05/24
3392 INR   +1.10%
12:04p GLAXOSMITHKLINE : Sees Positive Results From Relvar Ellipta Study
05/04 PFIZER : Drug Companies Pony Up in Illegal Marketing Cases, But Crit..
04/29 GLAXOSMITHKLINE : Glaxo, Save The Children Get Positive Opinion On A..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
05/18/2016 05/19/2016 05/20/2016 05/23/2016 05/24/2016 Date
3376(c) 3334(c) 3385(c) 3355(c) 3392(c) Last
7 407 3 609 2 686 2 593 3 690 Volume
-0.85% -1.24% +1.53% -0.89% +1.10% Change
More quotes
Financials ( INR)
Sales 2016 28 033 M
EBIT 2016 4 781 M
Net income 2016 4 360 M
Finance 2016 16 631 M
Yield 2016 1,69%
Sales 2017 31 901 M
EBIT 2017 6 768 M
Net income 2017 5 805 M
Finance 2017 16 604 M
Yield 2017 1,82%
P/E ratio 2016 68,22
P/E ratio 2017 49,68
EV / Sales 2016 9,61x
EV / Sales 2017 8,45x
Capitalization 286 152 M
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
05/25Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
12:04p GLAXOSMITHKLINE : Sees Positive Results From Relvar Ellipta Study
05/04 PFIZER : Drug Companies Pony Up in Illegal Marketing Cases, But Critics Wonder i..
05/03 GLAXOSMITHKLINE : DRAP may approve icrease in prices of medicines
04/29 GLAXOSMITHKLINE : Glaxo, Save The Children Get Positive Opinion On Antiseptic Ge..
04/27 EXTRA : GlaxoSmithKline Clarifies Guidance After "Encouraging" Start
04/27 TOP NEWS : GlaxoSmithKline Clarifies Guidance After "Encouraging" Start
04/25 GLAXOSMITHKLINE : ViiV Extends Licence Agreement For Dolutegravir
04/18 GLAXOSMITHKLINE : Opens GBP56 Million Facility In Ware (UPDATE)
More news
Sector news : Pharmaceuticals - NEC
10:24p BAYER : Monsanto rejects $62B takeover bid from Bayer AG as 'inadequate'
09:25p JOHNSON & JOHNSON : Washington, California sue over pelvic mesh implants
09:02p JOHNSON & JOHNSON : Healthcare Sector Stock Business Review
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE P...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions